|
|
|
|
Development - Cultivation Event
|
     |
|
| |
|
|
|
I n February 25, 2009, the NYC Chapter
continued its series of evening programs
entitled “The Next Generation.” Board Co-
Chair Heath McLendon and his wife Judy welcomed
guests to their home to hear from scientists engaged in
cutting-edge Alzheimer’s research.
The presenting scientists were Mary Sano, PhD,
Professor of Psychiatry and Director of the Alzheimer’s
Disease Research Center at Mount Sinai School of
Medicine, and her colleague, Hillel Grossman, MD, Co-
Director of the Clinical Core of the Alzheimer’s Disease
Research Center at Mount Sinai School of Medicine
and the Clinical Director of Mount Sinai Memory and
Aging Center.
A lively reception preceded a welcome by Heath
McLendon and an introduction by Lou-Ellen Barkan,
 Chapter President and CEO. Drs. Sano and Grossman
then presented “Developing New Treatments for
Alzheimer’s Disease,” a thorough discussion of how
new drugs are created; how clinical trials proceed
— knowing what to test for, safety, methodology and
steps in evaluation; Alzheimer’s disease treatments today
— including symptomatic treatments, cholinesterase
inhibitors (Aricept, Exelon, Razadyne), a glutamate
regulator (Namenda), and vitamins; and what we can
expect tomorrow — there are 600
compounds in clinical investigation
now.
The scientists also addressed
the question of what one can do
to minimize cognitive impairment:
treat treatable conditions, keep
informed, support research by
participating in trials and encourage
others to do the same.
If you would like to attend an upcoming event, please contact Karen Holland, Development Associate
at 646-744-2926 or
kholland@alznyc.org.
|
|
Previous
